Total Payments
$5,118
2024 Payments
$462.53
Companies
35
Transactions
238
Medicare Patients
2,920
Medicare Billing
$891,748
Payment Breakdown by Category
Food & Beverage$4,811 (94.0%)
Education$307.03 (6.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,811 | 221 | 94.0% |
| Education | $307.03 | 17 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $733.98 | 35 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $626.38 | 28 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $556.98 | 27 | $0 (2024) |
| Relypsa, Inc. | $374.74 | 18 | $0 (2019) |
| OPKO Pharmaceuticals, LLC | $336.88 | 18 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $230.23 | 13 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $189.81 | 11 | $0 (2018) |
| Veloxis Pharmaceuticals, Inc. | $175.76 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $161.07 | 9 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $160.34 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $462.53 | 21 | Ardelyx, Inc. ($101.00) |
| 2023 | $836.78 | 38 | GlaxoSmithKline, LLC. ($110.44) |
| 2022 | $719.15 | 33 | Alexion Pharmaceuticals, Inc. ($113.39) |
| 2021 | $462.46 | 21 | AstraZeneca Pharmaceuticals LP ($188.09) |
| 2020 | $139.59 | 6 | Otsuka America Pharmaceutical, Inc. ($46.62) |
| 2019 | $784.43 | 41 | Otsuka America Pharmaceutical, Inc. ($205.63) |
| 2018 | $1,011 | 44 | Otsuka America Pharmaceutical, Inc. ($204.50) |
| 2017 | $702.15 | 34 | Relypsa, Inc. ($178.87) |
All Payment Transactions
238 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: NEPHROLOGY | ||||||
| 11/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Cardio-renal | ||||||
| 07/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: NEPHROLOGY | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/02/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 06/25/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $35.59 | General |
| 06/13/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $19.41 | General |
| Category: NEPHROLOGY | ||||||
| 06/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/25/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: NEPHROLOGY | ||||||
| 03/18/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Hyperkalemia | ||||||
| 03/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/05/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 03/05/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 02/13/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: NEPHROLOGY | ||||||
| 02/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardio-renal | ||||||
| 01/11/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $31.60 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/08/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/07/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
| 11/30/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 668 | 1,301 | $311,511 | $163,582 |
| 2022 | 11 | 675 | 1,384 | $354,979 | $190,258 |
| 2021 | 10 | 778 | 1,625 | $450,757 | $247,327 |
| 2020 | 10 | 799 | 2,047 | $616,536 | $290,581 |
Total Patients
2,920
Total Services
6,357
Medicare Billing
$891,748
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 40 | 295 | $147,500 | $80,458 | 54.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 260 | 449 | $49,390 | $28,039 | 56.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 200 | $37,000 | $17,870 | 48.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 86 | 90 | $28,350 | $12,258 | 43.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 29 | 39 | $17,550 | $9,052 | 51.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 62 | 82 | $13,530 | $7,673 | 56.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 40 | $8,600 | $4,093 | 47.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 30 | 35 | $5,250 | $1,986 | 37.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,486 | $1,724 | 49.5% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 13 | 57 | $855.00 | $429.95 | 50.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 60 | 405 | $202,500 | $114,294 | 56.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 253 | 422 | $46,420 | $23,993 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 187 | $34,595 | $16,766 | 48.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 62 | 63 | $19,845 | $9,748 | 49.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 25 | 35 | $15,800 | $8,377 | 53.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 61 | $13,115 | $6,476 | 49.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 44 | 51 | $8,415 | $4,161 | 49.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $5,229 | $2,372 | 45.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 31 | 35 | $5,250 | $2,037 | 38.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 15 | $2,475 | $1,343 | 54.3% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 12 | 89 | $1,335 | $690.60 | 51.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 69 | 535 | $267,500 | $153,032 | 57.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 275 | 522 | $57,420 | $30,065 | 52.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 118 | 206 | $37,630 | $20,060 | 53.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 96 | 97 | $30,555 | $15,514 | 50.8% |
About Dr. Maxim Mirovski, MD
Dr. Maxim Mirovski, MD is a Nephrology healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1689797847.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maxim Mirovski, MD has received a total of $5,118 in payments from pharmaceutical and medical device companies, with $462.53 received in 2024. These payments were reported across 238 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,811).
As a Medicare-enrolled provider, Mirovski has provided services to 2,920 Medicare beneficiaries, totaling 6,357 services with total Medicare billing of $891,748. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Norfolk, VA
- Active Since 04/10/2007
- Last Updated 11/05/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1689797847
Products in Payments
- JYNARQUE (Drug) $713.65
- Velphoro (Drug) $559.49
- Veltassa (Drug) $418.19
- Auryxia (Drug) $260.46
- LOKELMA (Drug) $258.35
- FARXIGA (Drug) $253.94
- Kerendia (Drug) $230.23
- Rayaldee (Drug) $218.44
- ACTHAR (Biological) $193.54
- BENLYSTA (Biological) $161.07
- IBSRELA (Drug) $120.14
- RAYALDEE (Drug) $118.44
- SAMSCA (Drug) $115.14
- TARPEYO (Drug) $106.35
- LIVTENCITY (Drug) $101.50
- LUPKYNIS (Drug) $79.93
- FABRY-DISEASE (Drug) $71.02
- Dialyzers (Device) $66.89
- Rituxan (Biological) $66.40
- Crysvita (Drug) $65.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Norfolk
Dr. Thomas Mccune, Md, MD
Nephrology — Payments: $244,440
Nephrology $244,440
Ramin Tolouian, M.d, M.D
Nephrology — Payments: $231,178
Nephrology $231,178
Sandeep Magoon, Md, MD
Nephrology — Payments: $189,208
Nephrology $189,208
Wei Zhao, M.d, M.D
Nephrology — Payments: $7,259
Nephrology $7,259
Dr. Harlan Rust, Md, MD
Nephrology — Payments: $6,476
Nephrology $6,476
Dr. Suresh Rijhwani, Md, MD
Nephrology — Payments: $2,736
Nephrology $2,736